Tryptophan

Metal Connections#

Tryptophan metabolism is intimately tied to metal biology through several mechanisms. Iron as IDO/TDO cofactor: The rate-limiting enzymes of the kynurenine pathway are heme-iron-dependent. Iron dysregulation—whether excess or deficiency—alters pathway flux and shifts the balance between neuroprotective and neurotoxic metabolites.^{[2]Microbial Metallomics and Parkinson's Disease: A Unified Metal-Driven Framework Linking Ferroptosis, Dysbiosis, and alpha-Synuclein PathologyKaren Pendergrass · 2025Open reference 2 ↓}

Zinc and serotonin: Zinc is required for aromatic amino acid decarboxylase activity and modulates serotonin receptor binding. Zinc deficiency, common in many of the conditions discussed in this wiki, compounds tryptophan pathway disruption.

Manganese and tryptophan hydroxylase: manganese (Mn) exposure can alter TPH activity, disrupting serotonin synthesis in both gut and brain.

Cadmium and tryptophan depletion: cadmium (Cd) exposure is associated with altered tryptophan metabolism in animal models, potentially through oxidative depletion of cofactors.^{[3]Exposure to Cadmium and Its Impacts on Human Health: A Short ReviewPuthiyavalappil Rasin, Ashwathi A V, Sabeel M Basheer et al. · 2025Open reference 3 ↓}

Disease Relevance#

Tryptophan depletion or pathway imbalance appears across a remarkable range of conditions.

Autism spectrum disorder: Fecal kynurenate, indolelactate, and 5-HTP are significantly lower in ASD children. Brain activity in the insula and cingulate cortex mediates the relationship between tryptophan metabolite levels and ASD severity.^{[4]Aziz-Zadeh 2025 — Relationships Between Brain Activity, Tryptophan-Related Gut Metabolites, and Autism SymptomatologyLisa Aziz-Zadeh, Sofronia M. Ringold, Aditya Jayashankar et al. · 2025Open reference 4 ↓}

Depression: The "serotonin hypothesis" is an oversimplification, but IDO-mediated tryptophan steal—diverting substrate from serotonin to kynurenine—is well-documented in inflammatory depression.^{[5]Current Perspectives on Gut Microbiome Dysbiosis and DepressionCapuco A, Urits I, Hasoon J et al. · 2020Open reference 5 ↓}

Schizophrenia: Kynurenine pathway dysregulation with elevated kynurenic acid (an NMDA antagonist) is implicated in cognitive deficits.^{[6]The Gut Microbiome and Schizophrenia: The Current State of the Field and Clinical ApplicationsSzeligowski T, Yun AL, Lennox BR et al. · 2020Open reference 6 ↓}

Chronic kidney disease: Indoxyl sulfate, a uremic toxin derived from bacterial tryptophan metabolism, is a key driver of CKD progression and cardiovascular complications. See uremic-toxins.^{[7]Wehedy et al. 2022 — The Human Microbiome in CKD: A Double-Edged SwordWehedy, Ghali, Matboli · 2022Open reference 7 ↓}

Cardiovascular disease: Microbial IPA is atheroprotective; its depletion in Dysbiosis may accelerate atherosclerosis.^{[1]Emerging therapy targets to modulate microbiome-mediated effects evident in cardiovascular diseaseDorothea Katharina Hoffelner, Tim Hendrikx · 2025Open reference 1 ↓} PMDD: Tryptophan-serotonin pathway alterations are implicated in the neuroinflammatory component of premenstrual dysphoric disorder.^{[8]Cheng 2025 — Neuroinflammation in PMS and PMDD (Review)Cheng et al. · 2025Open reference 8 ↓}

Parkinson's disease: Kynurenine pathway metabolites contribute to neuroinflammation and dopaminergic neuron damage.^{[2]Microbial Metallomics and Parkinson's Disease: A Unified Metal-Driven Framework Linking Ferroptosis, Dysbiosis, and alpha-Synuclein PathologyKaren Pendergrass · 2025Open reference 2 ↓}